Phibro Animal Health reported $77.38M in Gross Profit on Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Align Technology ALGN:US USD 617.7M 1.47M
Ani Pharmaceuticals ANIP:US USD 57.91M 6.98M
Aurora Cannabis Inc ACB:CN CAD -22470000 354K
Bristol Myers Squibb BMY:US USD 8.89B 21M
Canopy Growth Corp WEED:CN CAD -2441000 6.26M
Corcept Therapeutics CORT:US USD 101.58M 1.19M
Eli Lilly And LLY:US USD 5.75B 391.2M
Endo International Ordinary Shares ENDP:US USD 364.83M 28.49M
Henry Schein HSIC:US USD 999M 85M
Idexx Laboratories IDXX:US USD 484.93M 21.7M
Knight Therapeutics Inc GUD:CN CAD 30.4M 7.89M
Merk MRK:US USD 10.47B 610M
Nektar Therapeutics NKTR:US USD 15.79M 2.86M
Pacira Pharmaceuticals PCRX:US USD 110.04M 6.75M
Patterson Companies PDCO:US USD 342.96M 14.87M
Phibro Animal Health PAHC:US USD 77.38M 8.74M
Prestige Brands PBH:US USD 150.4M 10.61M
Supernus Pharmaceuticals SUPN:US USD 144.37M 7.1M
Teva Pharmaceutical Industries TEVA:US USD 2.1B 390M
Zoetis ZTS:US USD 1.39B 7M